Director Dealing
21 May 2024
MYCELX Technologies Corporation
("MYCELX" or the "Company" (AIM: MYX)
Director Dealing
The Company announces that it was notified by André Schnabl, a Non-Executive Director of the Company, that on 20 May 2024, he purchased 71,598 common shares in the Company of US$0.025 each ("Common Shares"), at a price of £0.54 per Common Share. Following this transaction, Mr. Schnabl holds 118,011 Common Shares representing 0.51 per cent of the total issued capital of the Company.
For further information please contact:
MYCELX Technologies Corporation Connie Mixon, CEO Kim Slayton, CFO
|
Tel: +1 888 306 6843 |
Canaccord Genuity, Nominated Adviser Henry Fitzgerald-O'Connor Ana Ercegovic
|
Tel: + 44 20 7523 8000 |
Celicourt Mark Antelme Jimmy Lea Charlie Denley-Myerson |
Tel: +44 20 7770 6424 |
Notification of transactions of persons discharging managerial responsibility or connected persons
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| André Schnabl | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Non-Executive Director | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| MYCELX Technologies Corporation | ||||
b)
| LEI
| 213800UJZINIK2VD1G48
| ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
|
Common shares of US$0.025
ISIN: US62847T2024
| ||||
b)
| Nature of the transaction
| Purchase of Common Shares in GBP
| ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
n/a
n/a
| ||||
e)
| Date of the transaction
| 20/05/2024 | ||||
f)
| Place of the transaction
| London Stock Exchange (AIM) | ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.